The development of delirium can lead to severe and significant consequences for the patient. The primary aim of the study was to identify potential differences in clinical characteristics and medical management between elderly hospitalized patients with delirium and with and without coronavirus disease 2019 (COVID-19). A secondary aim was to report the short-term outcomes and possible predictors of outcomes of both patient groups. A retrospective study was conducted. Patients' records were screened for delirium. Clinical and laboratory data were collected, including baseline inflammatory markers. No significant difference was found between the patients with and the patients without COVID-19 regarding clinical characteristics and the dose of antipsychotic medication. COVID-19-positive delirium was not different from COVID-19-negative delirium in terms of length of hospital stay, intensive care, and antipsychotic needs. Monocyte to lymphocyte ratio (MLR) may be a predictor of survival in patients with COVID-19 and delirium.
[
Psychiatr Ann.
2022;52(8):338–348.]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.